Cushing’s syndrome is characterized by over production of hormone cortisol over a long period of time. The most common cause is the use of steroid drugs, but it can also occur from overproduction of cortisol by the adrenal glands. Cushing syndrome can result in exaggerated facial roundness, weight gain around the midsection and upper back, thinning of arms and legs.
Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/554
The global Cushing’s syndrome market is witnessing R&D of new products. For instance, in November 2019, The Committee for Medicinal Products for Human Use of the European Medicines Agency gave osilodrostat a positive opinion for the treatment of Cushing syndrome in adults.
Global Cushing’s Syndrome Market: Drivers
The global Cushing’s syndrome market is expected to propel growth of the global Cushing’s syndrome market over the forecast period. For instance, according to Orphanet Journal of Rare Disease, incidence of Cushing’s syndrome is estimated to be equal to 1–3 cases per million inhabitants per year, whereas its prevalence is close to 40 cases per million inhabitants in 2012.
Moreover, high prevalence of obesity is expected to propel growth of the global Cushing’s syndrome market. For instance, according to the Federal Research Center for Nutrition and Biotechnology, in 2018, (Russia) 60% of women and 50% of men aged over 30 were overweight with 27% of these men and 31% of these women officially obese.
Global Cushing’s Syndrome Market: Opportunities
R&D of new products is expected to offer lucrative growth opportunities for players in the global Cushing’s syndrome market. For instance, in September 2019, Strongbridge Biopharma plc announced positive result from the phase 3 clinical trial for RECORLEV (levoketoconazole) drug or the treatment of Cushing’s syndrome.
Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/554
North America is expected to witness significant growth in the global Cushing’s syndrome market, owing to high prevalence of obesity in the region. For instance, according to Centers for Disease Control and Prevention more than one-third of the U.S. adults have obesity which is a leading cause to Cushing’s syndrome that was 36.5% during 2011-2014.
North America is also expected to witness significant growth in the global Cushing’s syndrome market, owing to approval of launch of new products. For instance, in March 2020, the U.S Food and Drug Administration approved Isturisa (osilodrostat), an oral tablet for the treatment of Cushing’s syndrome.
Global Cushing’s Syndrome Market: Competitive Landscape
Major players operating in the global Cushing’s syndrome market include, Corcept Therapeutics Inc., HRA Pharma, Novartis AG, and Strongbridge Biopharma plc.
Global Cushing’s Syndrome Market: Key Developments
Major players operating in the global Cushing’s syndrome market are focused on R&D to expand their product portfolio. For instance, in June 2021, Strongbridge Biopharma plc received the U.S. patent entitled, “Methods of Treating Disease with Levoketoconazole” which covers a method of treating Cushing’s syndrome patients with RECORLEV (levoketoconazole) who also take metformin for Type 2 diabetes.
Major players operating in the global Cushing’s syndrome market are also focused on approval and launch of new products to expand their product portfolio. For instance, in June 2018, Novartis AG received the U.S Food and Drug Administration approval for Signifor (pasireotide) for the treatment of Cushing’s syndrome.
Global Cushing’s Syndrome Market: Segmentation
By Drug Type
By End User
- Hospitals Pharmacy
- Retail Pharmacy
- Drug Stores
- E-Commerce/Online Pharmacy
- North America
- Latin America
- Asia Pacific
- Middle East
Reasons to Purchase this Report
• Current and future of global Cushings Syndrome Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!!!!!!!
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Purchase This Premium Report With Discounted Rate @ https://www.coherentmarketinsights.com/insight/buy-now/554
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Cushings Syndrome Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Cushings Syndrome Industry Impact
Chapter 2 Global Cushings Syndrome Competition by Types, Applications, and Top Regions and Countries
2.1 Global Cushings Syndrome (Volume and Value) by Type
2.3 Global Cushings Syndrome (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Cushings Syndrome Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Cushings Syndrome Market Analysis
Chapter 6 East Asia Cushings Syndrome Market Analysis
Chapter 7 Europe Cushings Syndrome Market Analysis
Chapter 8 South Asia Cushings Syndrome Market Analysis
Chapter 9 Southeast Asia Cushings Syndrome Market Analysis
Chapter 10 Middle East Cushings Syndrome Market Analysis
Chapter 11 Africa Cushings Syndrome Market Analysis
Chapter 12 Oceania Cushings Syndrome Market Analysis
Chapter 13 South America Cushings Syndrome Market Analysis
Chapter 14 Company Profiles and Key Figures in Cushings Syndrome Business
Chapter 15 Global Cushings Syndrome Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027